GLOBAL PARP (POLY ADP-RIBOSE POLYMERASE) INHIBITOR MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Nov 2018 109

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

PARP means poly (adenosine diphosphate [ADP] -ribose) polymerase. It is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain (the PAR chain) and transfers them to the target proteins. This helps to restore DNA when it is damaged. DNA can be damaged by many factors, including exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors block an enzyme critical to the repair of single stranded breaks in DNA. Inhibition of this DNA repair enzyme can lead to cell death, particularly in cancer cells that carry deficiency in other DNA repair pathways.

Scope of the Report:

The U.S. is the major market of PARP inhibitor supported by PARPi for ovarian cancer in the market. The U.S. region is likely to experience further growth of PARP inhibitor market with upcoming PARP inhibitors and growing cases of cancer.

The worldwide market for PARP (Poly ADP-Ribose Polymerase) Inhibitor is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the PARP (Poly ADP-Ribose Polymerase) Inhibitor in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Tesaro
- Clovis Oncology
- AstraZeneca
- Abbvie

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Lynparza
- Diraparib
- Rucaparib
- Talazoparib
- Others

Market Segment by Applications, can be divided into
- Hospitals
- Pharmacial
- Retail
- Online

There are 15 Chapters to deeply display the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market.

Chapter 1, to describe PARP (Poly ADP-Ribose Polymerase) Inhibitor Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of PARP (Poly ADP-Ribose Polymerase) Inhibitor, with sales, revenue, and price of PARP (Poly ADP-Ribose Polymerase) Inhibitor, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of PARP (Poly ADP-Ribose Polymerase) Inhibitor, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, PARP (Poly ADP-Ribose Polymerase) Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe PARP (Poly ADP-Ribose Polymerase) Inhibitor sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Dec 19)

Description Scope of the Report: The worldwide market for Milk Protein Concentrate Powder is expected to grow at a CAG...

(Dec 19)

Description Scope of the Report: The worldwide market for Biotin Supplements is expected to grow at a CAGR of roughly ...

(Dec 19)

Description Scope of the Report: The global Smallpox Treatment market is valued at xx million USD in 2018 and is expec...

(Dec 19)

Scope of the Report: The global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market is valued at xx million USD in 2018...

(Dec 19)

Description Scope of the Report: The worldwide market for Alprazolam is expected to grow at a CAGR of roughly xx% over...

(Dec 19)

Description Scope of the Report: The worldwide market for Midecamycin (CAS 35457-80-8) is expected to grow at a CAGR of roughl...

GLOBAL PARP (POLY ADP-RIBOSE POLYMERASE) INHIBITOR MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy